Akoya Q1 2021 Earnings Report
Key Takeaways
Akoya Biosciences reported total revenue of $12.2 million for the first quarter of 2021, compared to $11.0 million in the first quarter of 2020. Product revenue was $10.0 million, with instrument revenue at $6.8 million and reagent revenue at $2.5 million.
Total revenue for the first quarter of 2021 was $12.2 million, compared to $11.0 million in the first quarter of 2020.
Product revenue was $10.0 million in the first quarter of 2021, compared to $8.9 million in the prior year period.
Instrument revenue was $6.8 million in the first quarter 2021, compared to $6.7 million in the first quarter 2020.
Reagent revenue was $2.5 million in the first quarter 2021, compared to $2.1 million in the first quarter 2020.
Akoya
Akoya
Akoya Revenue by Segment
Forward Guidance
Akoya expects full year 2021 revenue to be at least $52.0 million. The second quarter of 2021 is expected to have revenue growth of approximately 45% over the prior year quarter.
Revenue & Expenses
Visualization of income flow from segment revenue to net income